Justices Asked To Ban FCA Suits Relying On Patent Reviews <https://www.law360.com/governmentcontracts/articles/1823926?nl_pk=4126fe73-80ab-4e63-b526-ca8152f5c881&utm_source=newsletter&utm_medium=email&utm_campaign=governmentcontracts&utm_content=2024-04-11&read_main=1&nlsidx=0&nlaidx=1> By Andrew Karpan Valeant Pharmaceuticals is going to the U.S. Supreme Court to argue that information cited in Patent Trial and Appeal Board reviews cannot later be used by whistleblowers in False Claims Act lawsuits. Petition attached | Read full article » <https://www.law360.com/governmentcontracts/articles/1823926?nl_pk=4126fe73-80ab-4e63-b526-ca8152f5c881&utm_source=newsletter&utm_medium=email&utm_campaign=governmentcontracts&utm_content=2024-04-11&read_more=1&nlsidx=0&nlaidx=1> | Save to favorites » <https://www.law360.com/governmentcontracts/articles/1823926?nl_pk=4126fe73-80ab-4e63-b526-ca8152f5c881&utm_source=newsletter&utm_medium=email&utm_campaign=governmentcontracts&utm_content=2024-04-11&read_later=1&nlsidx=0&nlaidx=1>